If only so-called "modern" people paid more attention to what their ancestors and "less civilized" inhabitants of this Earth co-existing with us did and do today to treat infections and various illnesses and diseases -- if only. Sadly, there is already a FOR PROFIT corporation involved in developing potential "drugs" from this miracle clay given freely to us by Mother Nature. I believe it will just be a matter of time before the Heiltsuk First Nation People who entered into this compact with the Devil are swindled fully out of whatever they think they have retained of their rights by the people behind this corporation. We, who think we are so damn smart, continue to ignore Culpeper, author of English Physician and Complete Herbal in the mid-17th century: Culpeper believed medicine was a public asset rather than a commercial secret, and the prices physicians charged were far too expensive compared to the cheap and universal availability of nature's medicine. Wikipedia. So what if people die? It's all about the filthy lucre, darlings.
Press Release issued by the University of British Columbia
First Nations’ ancient medicinal clay shows promise against today’s worst bacterial infections
Naturally occurring clay from Kisameet Bay, B.C. — long used by the Heiltsuk First Nation for its healing potential — exhibits potent antibacterial activity against multidrug-resistant pathogens, according to new research from the University of British Columbia.
The researchers recommend the rare mineral clay be studied as a clinical treatment for serious infections caused by ESKAPE strains of bacteria.
The so-called ESKAPE pathogens — Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae,Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species — cause the majority of U.S. hospital infections and effectively ‘escape’ the effects of antibacterial drugs.
“Infections caused by ESKAPE bacteria are essentially untreatable and contribute to increasing mortality in hospitals,” said UBC microbiologist Julian Davies, co-author of the paper published today in the American Society for Microbiology’s mBio journal.
“After 50 years of over-using and misusing antibiotics, ancient medicinals and other natural mineral-based agents may provide new weapons in the battle against multidrug-resistant pathogens.”
The clay deposit is situated on Heiltsuk First Nation’s traditional territory, 400 kilometres north of Vancouver, Canada, in a shallow five-acre granite basin. The 400-million kilogram (400,000 tonne) deposit was formed near the end of the last Ice Age, approximately 10,000 years ago.
Local First Nations people have used the clay for centuries for its therapeutic properties—anecdotal reports cite its effectiveness for ulcerative colitis, duodenal ulcer, arthritis, neuritis, phlebitis, skin irritation, and burns.
“We’re fortunate to be able to partner with UBC on this significant research program” said Lawrence Lund, president of Kisameet Glacial Clay, a business formed to market cosmetic and medicinal products derived from the clay. “We hope it will lead to the development of a novel and safe antimicrobial that can be added to the diminished arsenal for the fight against the ESKAPE pathogens and other infection-related health issues plaguing the planet.”
In the in vitro testing conducted by Davies and UBC researcher Shekooh Behroozian, clay suspended in water killed 16 strains of ESKAPE bacteria samples from sources including Vancouver General Hospital, St. Paul’s Hospital, and the University of British Columbia’s wastewater treatment pilot plant.
No toxic side effects have been reported in the human use of the clay, and the next stage in clinical evaluation would involve detailed clinical studies and toxicity testing. Loretta Li, with UBC’s Department of Civil Engineering, is conducting mineralogical and chemical analyses of the clay as well. MITACS, Kisameet Glacial Clay Inc. and the Tally Fund supported the work.
Kisameet Clay Exhibits Potent Antibacterial Activity against the ESKAPE PathogensmBio American Society for Microbiology
January/February 2016 Volume 7 Issue 1 e01842-15
January/February 2016 Volume 7 Issue 1 e01842-15
No comments:
Post a Comment